UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000011033
Receipt number R000012919
Scientific Title Evaluation of physical therapy on physical function and QOL in patients with RA
Date of disclosure of the study information 2013/07/01
Last modified on 2013/06/25 11:29:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of physical therapy on physical function and QOL in patients with RA

Acronym

Evaluation of physical therapy in RA

Scientific Title

Evaluation of physical therapy on physical function and QOL in patients with RA

Scientific Title:Acronym

Evaluation of physical therapy in RA

Region

Japan


Condition

Condition

rheumatoid arthritis

Classification by specialty

Clinical immunology Orthopedics Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effects of muscle training with high or low speed on physical function and QOL in patients with RA

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

a. QOL evaluated by SF-36
b. muscle strength of knee extension

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

A group will do muscle training with high speed

Interventions/Control_2

B group will do muscle training with low speed

Interventions/Control_3

C group will receive evaluation only.

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

patients diagnosed as RA by the classification criteria reported in 1988 or 2010

Key exclusion criteria

exclusion criteria are as follows: extensive ADL limitations (class IV), moderate or severe cognitive disability, or severe lung or heart disease

Target sample size

90


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiromu Ito

Organization

Kyoto University Graduate School of Medicine

Division name

Department of the Control for Rheumatic Diseases

Zip code


Address

54, Kawahara-cho, Shogoin, Sakyo, Kyoto

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Kyoto University Hospital

Division name

Rheumatic Disease Center

Zip code


Address

54, Kawahara-cho, Shogoin, Sakyo, Kyoto

TEL


Homepage URL


Email



Sponsor or person

Institute

Kyoto University Hospital, Rheumatic Disease Center

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2013 Year 06 Month 25 Day

Date of IRB


Anticipated trial start date

2013 Year 07 Month 15 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 06 Month 25 Day

Last modified on

2013 Year 06 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012919


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name